Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivation
Small cell lung cancer (SCLC) is the most aggressive type of lung cancer with high mortality. One of the MYC family genes, MYC, MYCL or MYCN, is amplified in ~20% of the SCLCs; therefore, MYC proteins are potential therapeutic targets in SCLC patients. We investigated the therapeutic impact of Omomy...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Fiorentino, Francesco Paolo Tokgün, Elvan Solé-Sánchez, Sònia Giampaolo, Sabrina Tokgün, Onur Jauset González, Toni Kohno, Takashi Perucho, Manuel Soucek, Laura Yokota, Jun |
| description | Small cell lung cancer (SCLC) is the most aggressive type of lung cancer with high mortality. One of the MYC family genes, MYC, MYCL or MYCN, is amplified in ~20% of the SCLCs; therefore, MYC proteins are potential therapeutic targets in SCLC patients. We investigated the therapeutic impact of Omomyc, a MYC dominant negative, in a panel of SCLC cell lines. Strikingly, Omomyc suppressed the growth of all tested cell lines by inducing cell cycle arrest and/or apoptosis. Induction of G1 arrest by Omomyc was found to be dependent on the activation of CDKN1A, in part, through the TP73 pathway. Our results strongly indicate that SCLC cells carrying amplification of MYC, MYCL or MYCN are addicted to MYC function, suggesting that MYC targeting would be an efficient therapeutic option for SCLC patients. |
| format | Article |
| fullrecord | <record><control><sourceid>csuc_XX2</sourceid><recordid>TN_cdi_csuc_recercat_oai_recercat_cat_2072_493132</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>oai_recercat_cat_2072_493132</sourcerecordid><originalsourceid>FETCH-csuc_recercat_oai_recercat_cat_2072_4931323</originalsourceid><addsrcrecordid>eNrjZEh2L8ovL8lQKC4tKChKLS7OzM9TSKpU8I10VsjMy8hMyiwBiWTmKRTnJubkKCSnAomc0rx0heTEvOTUIrBAsUJ5JtCIkABTY4XEvBSFICdDoI7E5JLMskSQdh4G1rTEnOJUXijNzWDo5hri7KGbXFyaHF-UCjQnObEkPj8xE8EBYSMDc6N4E0tjQ2MjY3L0AAACPEov</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivation</title><source>Recercat</source><creator>Fiorentino, Francesco Paolo ; Tokgün, Elvan ; Solé-Sánchez, Sònia ; Giampaolo, Sabrina ; Tokgün, Onur ; Jauset González, Toni ; Kohno, Takashi ; Perucho, Manuel ; Soucek, Laura ; Yokota, Jun</creator><creatorcontrib>Fiorentino, Francesco Paolo ; Tokgün, Elvan ; Solé-Sánchez, Sònia ; Giampaolo, Sabrina ; Tokgün, Onur ; Jauset González, Toni ; Kohno, Takashi ; Perucho, Manuel ; Soucek, Laura ; Yokota, Jun</creatorcontrib><description>Small cell lung cancer (SCLC) is the most aggressive type of lung cancer with high mortality. One of the MYC family genes, MYC, MYCL or MYCN, is amplified in ~20% of the SCLCs; therefore, MYC proteins are potential therapeutic targets in SCLC patients. We investigated the therapeutic impact of Omomyc, a MYC dominant negative, in a panel of SCLC cell lines. Strikingly, Omomyc suppressed the growth of all tested cell lines by inducing cell cycle arrest and/or apoptosis. Induction of G1 arrest by Omomyc was found to be dependent on the activation of CDKN1A, in part, through the TP73 pathway. Our results strongly indicate that SCLC cells carrying amplification of MYC, MYCL or MYCN are addicted to MYC function, suggesting that MYC targeting would be an efficient therapeutic option for SCLC patients.</description><language>eng</language><subject>CDKN1A ; MYC ; MYCL ; SCLC ; Small cell lung cancer</subject><creationdate>2016</creationdate><rights>open access Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original. https://creativecommons.org/licenses/by/4.0</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,780,885,26972</link.rule.ids><linktorsrc>$$Uhttps://recercat.cat/handle/2072/493132$$EView_record_in_Consorci_de_Serveis_Universitaris_de_Catalunya_(CSUC)$$FView_record_in_$$GConsorci_de_Serveis_Universitaris_de_Catalunya_(CSUC)$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Fiorentino, Francesco Paolo</creatorcontrib><creatorcontrib>Tokgün, Elvan</creatorcontrib><creatorcontrib>Solé-Sánchez, Sònia</creatorcontrib><creatorcontrib>Giampaolo, Sabrina</creatorcontrib><creatorcontrib>Tokgün, Onur</creatorcontrib><creatorcontrib>Jauset González, Toni</creatorcontrib><creatorcontrib>Kohno, Takashi</creatorcontrib><creatorcontrib>Perucho, Manuel</creatorcontrib><creatorcontrib>Soucek, Laura</creatorcontrib><creatorcontrib>Yokota, Jun</creatorcontrib><title>Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivation</title><description>Small cell lung cancer (SCLC) is the most aggressive type of lung cancer with high mortality. One of the MYC family genes, MYC, MYCL or MYCN, is amplified in ~20% of the SCLCs; therefore, MYC proteins are potential therapeutic targets in SCLC patients. We investigated the therapeutic impact of Omomyc, a MYC dominant negative, in a panel of SCLC cell lines. Strikingly, Omomyc suppressed the growth of all tested cell lines by inducing cell cycle arrest and/or apoptosis. Induction of G1 arrest by Omomyc was found to be dependent on the activation of CDKN1A, in part, through the TP73 pathway. Our results strongly indicate that SCLC cells carrying amplification of MYC, MYCL or MYCN are addicted to MYC function, suggesting that MYC targeting would be an efficient therapeutic option for SCLC patients.</description><subject>CDKN1A</subject><subject>MYC</subject><subject>MYCL</subject><subject>SCLC</subject><subject>Small cell lung cancer</subject><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>XX2</sourceid><recordid>eNrjZEh2L8ovL8lQKC4tKChKLS7OzM9TSKpU8I10VsjMy8hMyiwBiWTmKRTnJubkKCSnAomc0rx0heTEvOTUIrBAsUJ5JtCIkABTY4XEvBSFICdDoI7E5JLMskSQdh4G1rTEnOJUXijNzWDo5hri7KGbXFyaHF-UCjQnObEkPj8xE8EBYSMDc6N4E0tjQ2MjY3L0AAACPEov</recordid><startdate>2016</startdate><enddate>2016</enddate><creator>Fiorentino, Francesco Paolo</creator><creator>Tokgün, Elvan</creator><creator>Solé-Sánchez, Sònia</creator><creator>Giampaolo, Sabrina</creator><creator>Tokgün, Onur</creator><creator>Jauset González, Toni</creator><creator>Kohno, Takashi</creator><creator>Perucho, Manuel</creator><creator>Soucek, Laura</creator><creator>Yokota, Jun</creator><scope>XX2</scope></search><sort><creationdate>2016</creationdate><title>Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivation</title><author>Fiorentino, Francesco Paolo ; Tokgün, Elvan ; Solé-Sánchez, Sònia ; Giampaolo, Sabrina ; Tokgün, Onur ; Jauset González, Toni ; Kohno, Takashi ; Perucho, Manuel ; Soucek, Laura ; Yokota, Jun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-csuc_recercat_oai_recercat_cat_2072_4931323</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>CDKN1A</topic><topic>MYC</topic><topic>MYCL</topic><topic>SCLC</topic><topic>Small cell lung cancer</topic><toplevel>online_resources</toplevel><creatorcontrib>Fiorentino, Francesco Paolo</creatorcontrib><creatorcontrib>Tokgün, Elvan</creatorcontrib><creatorcontrib>Solé-Sánchez, Sònia</creatorcontrib><creatorcontrib>Giampaolo, Sabrina</creatorcontrib><creatorcontrib>Tokgün, Onur</creatorcontrib><creatorcontrib>Jauset González, Toni</creatorcontrib><creatorcontrib>Kohno, Takashi</creatorcontrib><creatorcontrib>Perucho, Manuel</creatorcontrib><creatorcontrib>Soucek, Laura</creatorcontrib><creatorcontrib>Yokota, Jun</creatorcontrib><collection>Recercat</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Fiorentino, Francesco Paolo</au><au>Tokgün, Elvan</au><au>Solé-Sánchez, Sònia</au><au>Giampaolo, Sabrina</au><au>Tokgün, Onur</au><au>Jauset González, Toni</au><au>Kohno, Takashi</au><au>Perucho, Manuel</au><au>Soucek, Laura</au><au>Yokota, Jun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivation</atitle><date>2016</date><risdate>2016</risdate><abstract>Small cell lung cancer (SCLC) is the most aggressive type of lung cancer with high mortality. One of the MYC family genes, MYC, MYCL or MYCN, is amplified in ~20% of the SCLCs; therefore, MYC proteins are potential therapeutic targets in SCLC patients. We investigated the therapeutic impact of Omomyc, a MYC dominant negative, in a panel of SCLC cell lines. Strikingly, Omomyc suppressed the growth of all tested cell lines by inducing cell cycle arrest and/or apoptosis. Induction of G1 arrest by Omomyc was found to be dependent on the activation of CDKN1A, in part, through the TP73 pathway. Our results strongly indicate that SCLC cells carrying amplification of MYC, MYCL or MYCN are addicted to MYC function, suggesting that MYC targeting would be an efficient therapeutic option for SCLC patients.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_csuc_recercat_oai_recercat_cat_2072_493132 |
| source | Recercat |
| subjects | CDKN1A MYC MYCL SCLC Small cell lung cancer |
| title | Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T12%3A49%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-csuc_XX2&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Growth%20suppression%20by%20MYC%20inhibition%20in%20small%20cell%20lung%20cancer%20cells%20with%20TP53%20and%20RB1%20inactivation&rft.au=Fiorentino,%20Francesco%20Paolo&rft.date=2016&rft_id=info:doi/&rft_dat=%3Ccsuc_XX2%3Eoai_recercat_cat_2072_493132%3C/csuc_XX2%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |